The model imagines a new future in which traditional pharmacy distribution and access channels are bypassed.
Amar Urhekar
Advertisement
Articles by Amar Urhekar
Advertisement
Latest Updated Articles
TrumpRx and the Dawn of Direct-to-Consumer CommercializationOctober 24th 2025
Advertisement
Advertisement
Trending on PharmExec
1
New U.S. Guidance Lays Out Exemptions for 100% Tariffs: Report
2
Roundup: Hengrui Pharma and Novo Enter Exclusive License Agreement for HRS-1596, AstraZeneca Enters Collaboartion with Summit Therapeutics
3
Novo Reports Real-World Data Showing Weight Loss After Switch to Oral Semaglutide Pill
4
As Peptide Rulemaking Stalls, FDA Enforcement Moves Forward
5